---
figid: PMC5716981__fphar-08-00888-g009
figtitle: A2A adenosine receptors-triggered signal transduction cascade in cancer
  cells
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC5716981
filename: fphar-08-00888-g009.jpg
figlink: /pmc/articles/PMC5716981/figure/F9/
number: F9
caption: A2A adenosine receptors-triggered signal transduction cascade in cancer cells.
  CGS21680 agonist by activating A2AARs increases cell proliferation through a pathway
  dependent on PLC, PKCδ, pERK1/2, pJNK, and pAKT signaling. This effect is potently
  antagonized by the newly synthesized derivative TP455.
papertitle: Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation
  by the Novel Antagonist TP455.
reftext: Stefania Gessi, et al. Front Pharmacol. 2017;8:888.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9669684
figid_alias: PMC5716981__F9
figtype: Figure
redirect_from: /figures/PMC5716981__F9
ndex: 4a88ca2c-deca-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5716981__fphar-08-00888-g009.html
  '@type': Dataset
  description: A2A adenosine receptors-triggered signal transduction cascade in cancer
    cells. CGS21680 agonist by activating A2AARs increases cell proliferation through
    a pathway dependent on PLC, PKCδ, pERK1/2, pJNK, and pAKT signaling. This effect
    is potently antagonized by the newly synthesized derivative TP455.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - norpA
  - sl
  - Plc21C
  - rl
  - bsk
  - Akt
  - IGKV2D-29
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - MAPK3
  - MAPK1
  - MAPK8
  - MAPK9
  - MAPK10
  - AKT1
  - AKT2
  - AKT3
---
